Hsbc Holdings PLC lessened its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 59.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 7,473 shares of the medical technology company’s stock after selling 10,796 shares during the period. Hsbc Holdings PLC’s holdings in Hill-Rom were worth $728,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of the business. NEXT Financial Group Inc boosted its stake in Hill-Rom by 45.9% in the 4th quarter. NEXT Financial Group Inc now owns 318 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 100 shares during the period. Perigon Wealth Management LLC purchased a new stake in Hill-Rom in the 4th quarter worth $32,000. Cribstone Capital Management LLC purchased a new position in shares of Hill-Rom during the fourth quarter valued at about $49,000. Donoghue Forlines LLC purchased a new stake in shares of Hill-Rom in the fourth quarter worth about $202,000. Finally, Quantinno Capital Management LP purchased a new position in Hill-Rom during the 4th quarter valued at approximately $206,000. 83.75% of the stock is currently owned by institutional investors and hedge funds.
HRC has been the topic of a number of recent research reports. Morgan Stanley upped their price target on shares of Hill-Rom from $125.00 to $130.00 and gave the company an “overweight” rating in a research note on Monday, February 8th. Robert W. Baird raised their price objective on Hill-Rom from $105.00 to $115.00 and gave the company an “outperform” rating in a research note on Monday, February 8th. Finally, Raymond James raised their price target on Hill-Rom from $113.00 to $120.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 16th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $121.00.
Hill-Rom (NYSE:HRC) last released its quarterly earnings data on Thursday, February 4th. The medical technology company reported $1.53 EPS for the quarter, topping the consensus estimate of $1.05 by $0.48. Hill-Rom had a return on equity of 22.71% and a net margin of 7.74%. The company had revenue of $741.10 million for the quarter, compared to the consensus estimate of $654.41 million. During the same period last year, the business posted $1.13 EPS. Hill-Rom’s quarterly revenue was up 8.2% on a year-over-year basis. On average, analysts forecast that Hill-Rom Holdings, Inc. will post 5.36 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 31st. Investors of record on Monday, March 22nd were issued a $0.24 dividend. This is an increase from Hill-Rom’s previous quarterly dividend of $0.22. This represents a $0.96 annualized dividend and a dividend yield of 0.87%. The ex-dividend date was Friday, March 19th. Hill-Rom’s payout ratio is presently 17.36%.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment.
Recommended Story: What is a trade deficit?
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.